Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Jan 24, 2016 9:02pm
145 Views
Post# 24489213

RE:Time Stamp of the presentation

RE:Time Stamp of the presentationGreat summary! I was just catching up after vacation and about to make my notes from the presentation and now I don't have to!
Thank you for this contribution. This is what these boards should be used for... taking notes and collaborating on facts. How these nutballs are allowed on here with all the fud tactics without penalty (stockhouse advertisers should demand better) and how half of you still talk to them drives me crazy. Anyway, TLT and GGI are my last venture investments. This exchange is full of scum... which isn't news, folks with any serious net worth realized that many many years ago.

Good luck longs.



LaserStock29 wrote: Here's what I got minute by minute..  I skipped the mouse part, a touch of the early post presentation question with the laser muscle treatment.. but yeah..   This is kind of point form but it's a good reference if you want to watch and speed ahead too.

Enjoy.

Here's to 2016 

0.15 TSX June July once $1
0.22 Nasdaq by year end
0.43 1.5 and 2 mil this year  2016 is 10 mil 2017 20 and 30-50 in 3-5
114 efficacy 70-80 and tlc2000 80-90 %
144 Selling to chiro, podiatrists physio vetrainarians
210 TLC-2000 re-calibrating to cellular details is 90% efficacy
222 CPT code with tlc-2000….. Patent  Can Us, Europe
254 David smith 25 medical smith and full sales force 
323 Ontario, little Bc alberta trickle into USA adjacent   lots of low hanging conversion revenue
355 Partnered with 'National Leasing' Biggest in Canada (they are selling on 5 year lease) 8% 6% product 2% they're pocket… 25k cheque to TLT
432 $600 lease and 10k revenue for practioners per month
452 Alan Chen who brought Botox to Canada   value is marketing and patient referrals
541 Various sports teams; Toronto blue jays, raptors, SF giants, oakland athletics, Tom Brady, Drew Brees have both used it for they're knees for rehab.. 
555 Advisor Dr.James Andrews, opeing doors for sports teams side
631 Upgrade %   TLC-900-1000 is 50% existing.  
652 25000 x 400 and 25000x800 is 10-20 million just to existing.. Then there are provinces they haven't been in plus CPT code going after. 
734 Licenced PDT out of Virgina tech university and Acadia University out of Nova Scotia.  100% destruction in animal studies
804 Diagnostic capabilities through Flourescent capabilities
809 Immune response in animals  all at PMH  for phase 1b 
825 Phase 2b with Anderson MD Houston Texas. 
911 Drugs are 'black body; 
915 17 years since any upgrade in treatment
932 BCG destroys all the healthy cells 
948 Black body, tweak from Infrared to Ultraviolet to cover all 4 walls of the bladder, covering the entire BC 
1011 Tweaked the laser so now into MIBC 
1029 25% fail 6 months then 25% more in a year  250k 2 years 
1030 50-75k treatment. 100% animal effici
1043 Mouse Colon Cancer, Human Brain Cancer, Rat Brain Cancer. 
1055 Human Brain with Brain cancer works but with toxicicity.
1142 Lung, Melanoma and Brain cancer are next up.
1146 Blood brain barrier, small hole fibre optic line and light activate, through the metal bypasses it
1216 What is transferrin, delivering iron to everycell in body. Transitional metal.  Osmium Ruthenium are also Transitional. 
1245 10:1 uptake into cancer cells.. Using transferrin to achieve zero toxicity
1355 100% destruction 100% animals and re-challenge no cancer growth.. The killer T cells recognize and get the cancer.. 
1427 rat orthotopic, cancer in bladder, 80% recurrance and believe small micrometatis.. Where flourescence helps and can re-dose to get any remaining. 
1514 TLD-1433 180x more in cancer cells vs health
1532 4billion 20% is 800m simply on nimbc
1539 Brain, Lung, Colon as well
1603 ITA for laser device, received REB approval from PMH, waiting for ITA Febuary. 
1640 Safety Tolerability exploratory efficacy, recruit 3 start right away, 9 total for year end
1659 Exploratory effacacy in May/June for 3 patients. Should be catalyst for stock
1703 Uplisting upon the catalyst  20-40m depending on stock price
1715 Phase 2b slated for 2017 with PMH and MD Anderson
1721 Phase 3?  No it's bypassed on compassionate and ethical can't give fake drug and dummy laser
1740 Add a 6 month follow up on the phase 2b.
1745 Commercialization in 3 years, lots of catalysts mean time
1800 CE approval in 1Q 2016 (Europe)
1815 107m outstanding 10% inside ownership
1829 8 million; 4 million Ladenburn Thalaman in USA  EuroPacific in Canada 4 million each
1835 Fundraise was done in 24 hours oversubscribed
1845 Doug Lowe completed his research report on December 15th
1847 10 million warrants .50 strike  .75-$1.00  we can get the 10 million
1902 How much from the 8 million is left?  4.5 M  fully funded for the Phase 1b trials
1907 What is your Burn rate?  300k per month. So that's 15 months from today. 
1915 End of Presentation. 
2350 Ex Hockey players Retired Hall of Famers.. On the marketing side, looking into.
2459 Dr.James Andrews is a big name, very respected in the sports medicine community


Bullboard Posts